Dr. Pipas' appointment is a crucial move in bolstering GeoVa...
Dr. Pipas' appointment is a crucial move in bolstering GeoVax's resources for the progression of Gedeptin(R) and the firm's wider immune-oncology portfolio. His expertise is anticipated to aid the clinical developments of GeoVax's oncology programs.
Press Release: GeoVax Appoints Dr. Marc Pipas as Executive Medical Director, Oncology
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
3385Followers
0Following
8175Visitors
Follow